These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30117073)

  • 21. Origins of Yersinia pestis sensitivity to the arylomycin antibiotics and the inhibition of type I signal peptidase.
    Steed DB; Liu J; Wasbrough E; Miller L; Halasohoris S; Miller J; Somerville B; Hershfield JR; Romesberg FE
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3887-98. PubMed ID: 25896690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents.
    Wong JD; Barash JR; Sandfort RF; Janda JM
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1995-6. PubMed ID: 10858370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989].
    Rasoamanana B; Coulanges P; Michel P; Rasolofonirina N
    Arch Inst Pasteur Madagascar; 1989; 56(1):37-53. PubMed ID: 2633713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
    Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.
    Lonsway DR; Urich SK; Heine HS; McAllister SK; Banerjee SN; Schriefer ME; Patel JB
    J Clin Microbiol; 2011 May; 49(5):1956-60. PubMed ID: 21411569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of viable Yersinia pestis by fluorescence in situ hybridization using peptide nucleic acid probes.
    Kenny JH; Zhou Y; Schriefer ME; Bearden SW
    J Microbiol Methods; 2008 Oct; 75(2):293-301. PubMed ID: 18655809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance of experimental antibiotic resistant variants of Yersinia pestis EV76 (NIIEG line) to modern marker antibiotics].
    Ivanova VS; Morozova IV; Lebedeva SA
    Antibiot Khimioter; 2006; 51(11-12):18-23. PubMed ID: 18318143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents.
    Frean J; Klugman KP; Arntzen L; Bukofzer S
    J Antimicrob Chemother; 2003 Aug; 52(2):294-6. PubMed ID: 12865386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
    Smith MD; Vinh DX; Nguyen TT; Wain J; Thung D; White NJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2153-4. PubMed ID: 8540736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.
    Lindler LE; Fan W; Jahan N
    J Clin Microbiol; 2001 Oct; 39(10):3649-55. PubMed ID: 11574586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of eleven commercially available rapid tests for detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis.
    Zasada AA; Formińska K; Zacharczuk K; Jacob D; Grunow R
    Lett Appl Microbiol; 2015 May; 60(5):409-13. PubMed ID: 25598285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole Slide Imaging for High-Throughput Sensing Antibiotic Resistance at Single-Bacterium Level and Its Application to Rapid Antibiotic Susceptibility Testing.
    Song D; Liu H; Ji H; Lei Y
    Molecules; 2019 Jul; 24(13):. PubMed ID: 31277201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis.
    Ferreras JA; Ryu JS; Di Lello F; Tan DS; Quadri LE
    Nat Chem Biol; 2005 Jun; 1(1):29-32. PubMed ID: 16407990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new approach to determine the susceptibility of bacteria to antibiotics directly from positive blood culture bottles in two hours.
    March GA; García-Loygorri MC; Simarro M; Gutiérrez MP; Orduña A; Bratos MA
    J Microbiol Methods; 2015 Feb; 109():49-55. PubMed ID: 25529277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.
    San Jose G; Jackson ER; Haymond A; Johny C; Edwards RL; Wang X; Brothers RC; Edelstein EK; Odom AR; Boshoff HI; Couch RD; Dowd CS
    ACS Infect Dis; 2016 Dec; 2(12):923-935. PubMed ID: 27676224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B.
    Anisimov AP; Dentovskaya SV; Titareva GM; Bakhteeva IV; Shaikhutdinova RZ; Balakhonov SV; Lindner B; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA
    Infect Immun; 2005 Nov; 73(11):7324-31. PubMed ID: 16239530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen
    Makdasi E; Atiya-Nasagi Y; Gur D; Zauberman A; Schuster O; Glinert I; Shmaya S; Milrot E; Levy H; Weiss S; Chitlaru T; Mamroud E; Laskar O
    Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of
    Dudte SC; Hinnebusch BJ; Shannon JG
    Front Cell Infect Microbiol; 2017; 7():358. PubMed ID: 28848716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.